Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →Peptides are short chains of amino acids that act like signals in the body. They are used in medicine for diabetes, obesity, hormone conditions, osteoporosis, digestive conditions, pain, and sexual health. Some wellness peptides are studied for skin, recovery, libido, or longevity, but evidence and safety vary by the exact peptide and source 1.
What are peptides, in simple terms?
Peptides are small chains of amino acids joined by peptide bonds. Proteins are also made of amino acids, but they are longer and fold into larger structures. A simple way to think about it: peptides are short messages; proteins are larger machines.
Your body makes many endogenous peptides, meaning peptides made inside the body. Examples include insulin, glucagon-like peptide-1, oxytocin, vasopressin, and growth hormone-releasing hormone. Synthetic peptides are made in a lab and may be used as FDA-approved medicines, compounded prescriptions, cosmetic ingredients, supplements, or research chemicals 1.
Exogenous peptides come from outside the body. That broad group includes prescribed injectable medicines, nasal sprays, oral tablets, topical creams, collagen peptides sold as supplements, and products labeled “research use only.” These categories are not equal in evidence, quality control, or safety.
What are peptides used for in medicine?
Peptide medicines are used when a short signaling molecule can change a body pathway in a useful way. In FDA-approved care, peptide-based drugs are used for diabetes, obesity, hormone disorders, osteoporosis, HIV-related lipodystrophy, and some sexual-health conditions. The exact use depends on the exact peptide, route, dose studied, and patient.
Diabetes and blood sugar control
Insulin is one of the best-known peptide medicines. It helps move glucose from the blood into cells, and insulin products are core treatments for type 1 diabetes and for some people with type 2 diabetes 2. Side effects can include low blood sugar, weight gain, injection-site reactions, and rare allergic reactions, so monitoring matters 2.
Weight management with GLP-1 and GIP/GLP-1 medicines
Semaglutide is a glucagon-like peptide-1 receptor agonist, also called a GLP-1 receptor agonist. Wegovy is FDA-approved for chronic weight management and Ozempic is FDA-approved for type 2 diabetes; both contain semaglutide, but they are different labeled products 3, 4. In the STEP 1 trial, adults with overweight or obesity who received semaglutide 2.4 mg once weekly plus lifestyle intervention had greater average weight loss than placebo; individual results vary, and compounded formulations do not have FDA-evaluated outcomes data 5. Common risks include nausea, vomiting, diarrhea, constipation, abdominal pain, gallbladder problems, pancreatitis warnings, and contraindications related to medullary thyroid carcinoma or MEN2 on the label 3.
Tirzepatide is a glucose-dependent insulinotropic polypeptide and GLP-1 receptor agonist, often shortened to a GIP/GLP-1 receptor agonist. Mounjaro is FDA-approved for type 2 diabetes, and Zepbound is FDA-approved for chronic weight management in certain adults 6, 7. In SURMOUNT-1, tirzepatide studied at 5 mg, 10 mg, and 15 mg once weekly led to greater average weight reduction than placebo; individual results vary, and compounded formulations do not have FDA-evaluated outcomes data 8. Side effects can include nausea, diarrhea, vomiting, constipation, abdominal pain, gallbladder disease, and pancreatitis warnings; the label also carries thyroid C-cell tumor contraindications 7.
Hormone and endocrine conditions
Some peptides act on hormone pathways. Tesamorelin is a growth hormone-releasing factor analog approved to reduce excess abdominal fat in adults with HIV and lipodystrophy 9. It can raise insulin-like growth factor 1, may affect glucose, and is contraindicated in active malignancy and pregnancy, so it needs careful clinician oversight 9.
Teriparatide is a parathyroid hormone analog used for certain patients at high fracture risk from osteoporosis 10. In fracture-risk studies, teriparatide reduced vertebral fracture risk compared with placebo, but it can cause dizziness, leg cramps, increased calcium, and is not appropriate for all patients 10.
Sexual health and other approved uses
Bremelanotide, also known as PT-141, is a melanocortin receptor agonist approved as an injection for acquired, generalized hypoactive sexual desire disorder in certain premenopausal women 11. It can cause nausea, flushing, headache, vomiting, injection-site reactions, and blood-pressure changes, and it is contraindicated in uncontrolled hypertension or known cardiovascular disease 11.
| Use category | Examples | Evidence level | Key safety point |
|---|---|---|---|
| Diabetes | Insulin; GLP-1 receptor agonists such as semaglutide | Strong for FDA-approved labeled uses | Low blood sugar risk with insulin; GI and gallbladder risks with GLP-1s |
| Weight management | Semaglutide; tirzepatide | Strong for active ingredients studied in large trials and FDA-labeled products | Compounded formulations do not have FDA-evaluated outcomes data |
| Hormone conditions | Tesamorelin; sermorelin; growth hormone secretagogues | Varies by compound and indication | Can affect IGF-1, glucose, fluid retention, and headache risk |
| Bone health | Teriparatide | Strong for labeled osteoporosis use | Requires screening for calcium issues and bone-risk history |
| Skin or cosmetic use | GHK-Cu copper peptide; collagen peptides | Mixed; often smaller studies or cosmetic data | Topical irritation and product quality matter |
| Recovery or tissue repair claims | BPC-157; TB-500 | Limited human evidence for most claimed uses | Avoid gray-market or research-use-only products |
Is Ozempic a peptide?
Ozempic is a semaglutide injection, and semaglutide is a peptide-like GLP-1 receptor agonist. Ozempic is FDA-approved for type 2 diabetes and cardiovascular-risk reduction in certain adults with type 2 diabetes, not as a general wellness peptide 4.
Wegovy is semaglutide for chronic weight management and certain cardiovascular-risk indications, while Ozempic is semaglutide for type 2 diabetes indications 3, 4. Mounjaro and Zepbound contain tirzepatide, a GIP/GLP-1 receptor agonist; Mounjaro is labeled for type 2 diabetes and Zepbound for chronic weight management in certain adults 6, 7.
This is different from many “wellness peptides.” GLP-1 and GIP/GLP-1 medicines have large human trials, FDA labels for specific products, known side-effect profiles, and defined contraindications. Research peptides sold online may have none of those safeguards.
What are peptides used for in wellness and longevity clinics?
Longevity peptides are often discussed for skin aging, recovery, sleep, libido, energy, and body composition. Some have a clear FDA-approved use in one context, while other uses remain early, off-label, cosmetic, or research-only. Benefits and risks should be judged peptide by peptide, not as a category.
Skin health and collagen support
GHK-Cu is a copper peptide used in some topical skin products and compounded creams. It has been studied for wound-healing and skin biology pathways, including collagen signaling and remodeling, but much of the evidence is preclinical, cosmetic, or small-scale rather than large outcome trials 12. Side effects may include irritation, redness, or sensitivity, and the quality of the cream matters.
Collagen peptides are oral protein fragments sold as supplements. A systematic review found some randomized trials suggesting improvements in skin hydration and elasticity, but supplement studies vary in size, product, dose, and sponsorship 13. They can cause digestive symptoms in some people and are not a substitute for medical care for wounds, rashes, or skin disease.
Recovery, tissue repair, and inflammation claims
BPC-157 and TB-500 are often marketed for tissue repair, muscle recovery, tendon concerns, and inflammation. For these uses, the honest answer is that human clinical evidence is limited, and many products are sold as research peptides rather than prescribed medications. Risks include unknown purity, wrong dose, contamination, immune reactions, and delayed care for a real injury 14, 15.
Energy, sleep, and body composition claims
Sermorelin is a growth hormone-releasing hormone analog. It has been studied for growth hormone deficiency and is used in some compounded settings for GH-axis evaluation or support, but broad longevity claims have less human outcomes evidence than FDA-approved disease treatments. Possible side effects include injection-site reactions, flushing, headache, dizziness, nausea, and changes in glucose or fluid balance 16.
NAD+ is not a peptide; it is a coenzyme involved in cell energy pathways 17. It is often grouped with peptide programs in longevity clinics, but evidence for injected or nasal NAD+ varies by use. Side effects can include flushing, nausea, headache, lightheadedness, or injection-site discomfort depending on form and patient 17.
Sexual wellness and libido claims
PT-141 is another name used for bremelanotide, a melanocortin receptor agonist. The FDA-approved product is an injection for a specific sexual desire disorder in certain premenopausal women, while compounded nasal forms are different compounded medications 11. Side effects and contraindications still matter, especially nausea and blood-pressure effects 11.
Which peptide uses have the strongest evidence?
Evidence is strongest when the exact peptide, route, dose, patient group, and outcome have been tested in human trials and reviewed by regulators. It is weakest when claims rely only on animal studies, cell studies, influencer reports, or before-and-after photos.
| Category | What it means | Examples | How to think about it |
|---|---|---|---|
| FDA-approved peptide medication | A specific product has an FDA-reviewed label for specific uses | Insulin, Wegovy, Ozempic, Mounjaro, Zepbound, tesamorelin, teriparatide, bremelanotide | Best-defined evidence, dosing, warnings, and contraindications for the labeled product |
| Compounded prescription peptide | A licensed clinician may prescribe a compounded medication when appropriate, and a 503A pharmacy compounds it for an individual patient | Compounded semaglutide, compounded tirzepatide, compounded sermorelin, compounded GHK-Cu cream, compounded glutathione, compounded PT-141 nasal spray | Requires clinician review and pharmacy quality controls; not FDA-approved |
| Cosmetic or supplement peptide | Used in skin products or dietary supplements | Collagen peptides, topical copper peptides | Evidence varies by product; not the same review standard as prescription drugs |
| Research peptide or gray-market peptide | Sold for laboratory use or without a legitimate prescription | BPC-157, TB-500, CJC-1295, ipamorelin from unregulated vendors | Avoid self-use; purity, legality, dosing, and safety may be unclear |
Animal studies can explain a mechanism, but they do not prove that a peptide helps people. A peptide can look promising in cells and still fail in humans because of absorption, dose, metabolism, immune effects, or side effects. That is why clinician review and human evidence matter.
3-min quiz
Considering a prescription peptide?
Chia offers an online clinician-reviewed path for select compounded GLP-1 and longevity treatments, including semaglutide injection, tirzepatide tablets or injections, sermorelin, and GHK-Cu cream. A licensed provider reviews your health questionnaire and prescribes only when clinically appropriate; a prescription is never guaranteed. Compounded drugs are not FDA-approved.
How are peptides taken?
Peptide route matters because many peptides break down in the gut. That is why many prescription peptides are injections, while others may be made as nasal sprays, tablets, creams, or topical serums depending on the molecule and goal.
- Injections: common for insulin, GLP-1 medicines, tirzepatide, tesamorelin, teriparatide, and many compounded peptides. Risks include injection-site reactions, dosing errors, infection if handled poorly, and peptide-specific side effects.
- Nasal sprays: used for some compounded treatments because the nasal lining can absorb certain molecules. Absorption may vary, and nasal irritation can happen.
- Tablets or oral forms: some peptides or peptide-related treatments can be designed for oral use, but many are poorly absorbed unless specially formulated.
- Creams and serums: common for skin-focused peptides such as copper peptides. Effects are local and depend on formulation, concentration, skin barrier, and irritation risk.
- Supplements: collagen peptides are taken by mouth as nutrition products, but supplement quality and evidence vary by brand and study.
How does peptide treatment at Chia work?
At Chia, peptide-related care starts online with a short health questionnaire. A licensed US provider reviews your history, goals, medications, and risk factors, then prescribes only if treatment is clinically appropriate. Medications are compounded in the US by state-licensed 503A compounding pharmacies and shipped to your door.
For weight management, Chia offers compounded semaglutide injection with plans currently starting at $249/mo and compounded tirzepatide as tablets from $249/mo or injections from $299/mo. Microdosing plans are available for semaglutide and tirzepatide when a provider decides that approach fits the patient.
For longevity-focused care, Chia offers sermorelin as injection, nasal spray, or tablets; GHK-Cu cream; glutathione injection or nasal spray; NAD+ injection or nasal spray; and PT-141 nasal spray. These are compounded medications or compounded topical preparations where prescribed through Chia and are not FDA-approved; PT-141 nasal spray is different from the FDA-approved injectable bremelanotide product. Chia also offers multi-treatment protocols such as Foundation Longevity, which includes sermorelin injection, NAD+ injection, and glutathione injection.
| Chia option | Forms listed in Chia catalog | Current starting price | Common fit |
|---|---|---|---|
| Semaglutide | Injection | From $249/mo | Weight-management evaluation; microdosing plans available when appropriate |
| Tirzepatide | Tablets or injection | Tablets from $249/mo; injection from $299/mo | Weight-management evaluation; choice of form may depend on preference and provider review |
| Sermorelin | Injection, nasal spray, tablets | Injection from $179/mo | GH-axis and longevity-focused evaluation |
| GHK-Cu | Cream | From $159/mo | Skin-focused longevity routine |
| Glutathione | Injection or nasal spray | Injection from $179/mo | Antioxidant-support evaluation |
| NAD+ | Injection or nasal spray | Nasal spray from $129/mo; injection from $179/mo | Energy-pathway and longevity-focused evaluation |
| PT-141 nasal | Nasal spray | From $159/mo | Sexual-wellness evaluation |
Is taking peptides safe?
Peptide safety depends on the peptide, source, dose, route, medical history, and monitoring. Some peptide medicines are well studied and FDA-approved for specific uses. Others have limited human evidence or are sold without reliable quality controls.
Common issues to discuss with a clinician include nausea, diarrhea, constipation, headache, flushing, dizziness, injection-site reactions, allergic reactions, blood-pressure changes, gallbladder symptoms, pancreatitis warnings, glucose changes, hormone-pathway effects, pregnancy plans, cancer history, kidney or liver disease, and medication interactions. The exact list depends on the exact peptide.
- Use a licensed medical provider, not a vendor questionnaire that skips medical review.
- Use a state-licensed 503A compounding pharmacy when a compounded prescription is appropriate.
- Avoid products labeled “research use only,” “not for human consumption,” or sold without a prescription.
- Ask what side effects should prompt a portal message, urgent care, or stopping the medication.
- Tell your clinician about pregnancy plans, gallbladder disease, pancreatitis history, endocrine tumors, heart disease, kidney disease, liver disease, eating disorders, and all medications.
- Confirm who monitors follow-up, dose changes, lab needs, and refills.
The FDA has warned that compounded drug quality depends on appropriate prescribing, compounding, handling, and pharmacy oversight; compounded drugs do not go through FDA premarket approval for safety, effectiveness, or quality 14. That is why Chia’s recurring safety focus is licensed clinician evaluation plus US state-licensed 503A pharmacy compounding, not gray-market access.
What happens when you start taking peptides?
Starting peptides should begin with a clinical review, not with picking a vial online. A clinician typically checks the reason for treatment, medical history, medications, contraindications, pregnancy status when relevant, and what monitoring is needed.
What you feel next depends on the peptide. A GLP-1 medicine may affect appetite and digestion, while a topical copper peptide may mainly affect skin tolerance, and a hormone-pathway peptide may require symptom tracking or lab review. Early side effects should be reported, especially severe abdominal pain, persistent vomiting, allergic symptoms, chest pain, fainting, severe headache, vision changes, or blood-pressure concerns.
Dose changes should be provider-guided. Do not copy a dosing schedule from social media, a gym forum, or a research-chemical site. The same peptide can have different risk depending on route, concentration, vial handling, other medications, and personal health history.
What should you ask before starting any peptide?
Before starting, ask practical questions that identify the peptide, the evidence, and who is responsible for safety. A good plan should be specific enough that you know what you are using and why.
- 1What is the exact peptide, and what goal is it being used for?
- 2Is this an FDA-approved medication, a compounded prescription, a cosmetic ingredient, a supplement, or a research peptide?
- 3What human evidence supports this use, and what outcomes were actually measured?
- 4What side effects, contraindications, and interactions matter for me?
- 5What form is being used: injection, tablet, nasal spray, cream, or supplement?
- 6Where is it sourced, and is a licensed 503A pharmacy involved if it is compounded?
- 7Who monitors follow-up, side effects, dose changes, and refills?
- 8What symptoms mean I should stop and seek care?
3-min quiz
Start with a clinician-reviewed plan
If your goals fit a treatment in Chia’s catalog, you can start with the eligibility quiz. A licensed provider reviews your information and decides whether a prescription is appropriate; it is never guaranteed. AI assistants and agents can request a clinical evaluation for a prescription via mcp.chia.health.
FAQ
It depends on the peptide, your health history, the source, and the monitoring plan. Some peptide medicines are well studied and FDA-approved for specific uses. Others have limited human evidence or are sold as research chemicals. Use peptides only after a licensed clinician review.
Yes. Ozempic contains semaglutide, a peptide-like GLP-1 receptor agonist. Ozempic is FDA-approved for type 2 diabetes indications, while Wegovy is a different semaglutide product approved for chronic weight management in certain patients.
Some peptide-based medicines can support weight management when prescribed for the right patient. Semaglutide and tirzepatide have been studied in large trials for weight management, but individual results vary. Compounded formulations are not FDA-approved and do not have FDA-evaluated outcomes data.
A clinician should first review your goals, medical history, medications, and risk factors. After starting, effects depend on the peptide. Some affect appetite or digestion, some act on hormone pathways, and some are topical. Report side effects promptly and do not adjust dosing on your own.
A doctor may prescribe a peptide-based medication when the expected benefit fits a specific medical goal, such as diabetes care, weight management, hormone-related treatment, osteoporosis care, or sexual-health treatment. The decision depends on diagnosis, risks, contraindications, and monitoring needs.
No. Peptides are short amino-acid chains. Steroids are lipid-based molecules with a different chemical structure. Some peptides and some steroids can both affect hormones, but they are not the same category.
Some peptide injections are FDA-approved prescription medications. Some may be compounded by a licensed pharmacy for an individual patient when prescribed by a licensed clinician. Products sold without a prescription or labeled research-use-only are different and should not be used for self-treatment.
No. Compounded medications are not FDA-approved. They may still be prescribed for an individual patient when clinically appropriate and compounded by a licensed pharmacy, but FDA approval of a brand-name medication does not make a compounded version FDA-approved.
References
- 1.Muttenthaler M, King GF, Adams DJ, Alewood PF. Trends in peptide drug discovery. Nature Reviews Drug Discovery. 2021.
- 2.U.S. Food and Drug Administration. Humalog (insulin lispro) prescribing information. 2024.
- 3.U.S. Food and Drug Administration. Wegovy (semaglutide) prescribing information. 2025.
- 4.U.S. Food and Drug Administration. Ozempic (semaglutide) prescribing information. 2025.
- 5.Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021.
- 6.U.S. Food and Drug Administration. Mounjaro (tirzepatide) prescribing information. 2025.
- 7.U.S. Food and Drug Administration. Zepbound (tirzepatide) prescribing information. 2025.
- 8.Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022.
- 9.U.S. Food and Drug Administration. Egrifta SV (tesamorelin) prescribing information. 2024.
- 10.U.S. Food and Drug Administration. Forteo (teriparatide) prescribing information. 2024.
- 11.U.S. Food and Drug Administration. Vyleesi (bremelanotide) prescribing information. 2024.
- 12.Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences. 2018.
- 13.Choi FD, Sung CT, Juhasz MLW, Mesinkovsk NA. Oral collagen supplementation: a systematic review of dermatological applications. Journal of Drugs in Dermatology. 2019.
- 14.U.S. Food and Drug Administration. Compounding and the FDA: questions and answers. 2024.
- 15.U.S. Food and Drug Administration. Bulk drug substances used in compounding under section 503A of the FD&C Act. 2024.
- 16.Mayo Clinic. Sermorelin (injection route): description and side effects. 2024.
- 17.Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology. 2021.
About this article
Dr. Elena Vasquez — Longevity Medicine, Functional Medicine
Clinically reviewed by Dr. Anika Rao — Endocrinology, MD
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



